Medicine Recommendations

LSCMMG

Red

BwD

Red

Red

Red

Red

Red

Red

Red

Red

Rituximab

Date Posted: 01 - Sep - 2018

BNF chapter: Immune system and Malignant Disease

Expand/Collapse

Autoimmune haemolytic anaemia

Red

Red

Red

Red

Red

Red

Red

Red

Red

Rituximab

Date Posted: 01 - Sep - 2018

BNF chapter: Immune system and Malignant Disease

Expand/Collapse

Idiopathic thrombocytopenia purpura

Grey

Pending

Grey

Grey

Pending

Grey

Grey

Grey

Grey

Rituximab

Date Posted: 01 - Jul - 2018

BNF chapter: Immune system and Malignant Disease

Expand/Collapse

Membranous glomerulonephritis

Grey

Pending

Grey

Grey

Pending

Grey

Grey

Grey

Grey

Rituximab

Date Posted: 01 - Jul - 2018

BNF chapter: Immune system and Malignant Disease

Expand/Collapse

Relapsing steroid sensitive nephrotic syndrome in adults

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Rivaroxaban 10mg tablets

Date Posted: 01 - Jun - 2018

BNF chapter: Cardiovascular system

Expand/Collapse

Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and extended prevention of recurrent DVT and PE in adults

NICE TA261 - Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism

Red

Red

Red

Red

Red

Red

Red

Red

Red

Rivaroxaban

Date Posted: 01 - May - 2013

BNF chapter: Cardiovascular system

Expand/Collapse

Prevention of venous thromboembolism after total hip or total knee replacement in adults (NICE TA170)

NICE TA170 - Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults

Green

Green

Green

Green

Green

Green

Green

Green

Green

Rivaroxaban

Date Posted: 01 - Jul - 2014

BNF chapter: Cardiovascular system

Expand/Collapse

Prevention of stroke and systemic embolism in people with atrial fibrillation (NICE TA256)

NICE TA256 - Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Pending

Rivaroxaban

Date Posted: 01 - Jul - 2014

BNF chapter: Cardiovascular system

Expand/Collapse

Treatment of deep vein thrombosis and prevention of recurrent DVT and pulmonary embolism (NICE TA261)

NICE TA261 - Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism

Amber 0

Green

Amber 0

Amber 0

Green

Amber 0

Amber 0

Amber 0

Amber 0

Rivaroxaban

Date Posted: 01 - Jul - 2013

BNF chapter: Cardiovascular system

Expand/Collapse

Pulmonary embolism and recurrent venous thromboembolism
(NICE TA287)

NICE TA287 - Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism

Amber 0

Green

Amber 0

Amber 0

Green

Amber 0

Amber 0

Amber 0

Amber 0

Rivaroxaban

Date Posted: 01 - Apr - 2015

BNF chapter: Cardiovascular system

Expand/Collapse

Preventing adverse outcomes after acute management of acute coronary syndrome (NICE TA335)

NICE TA335 - Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome

Green

Amber 0

Green

Pending

Amber 0

Green

Pending

Pending

Green

Rivaroxaban with aspirin

Date Posted: 01 - Oct - 2018

BNF chapter: Cardiovascular system

Expand/Collapse

Prevention of cardiac events in patients with coronary (CAD) or peripheral artery Disease (PAD) (NICE TA607)

NICE TA607 - Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease

Amber 0

Pending

Amber 0

Amber 0

Pending

Amber 0

Amber 0

Amber 0

Pending

Rivastigmine

Date Posted: 01 - Mar - 2015

BNF chapter: Central nervous system

Expand/Collapse

Alzheimer's Dementia (NICE TA 217)

NICE TA217 - Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease

MHRA Drug Safety Update - Rivastigmine (Exelon) transdermal patch: risk of medication errors

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Roflumilast

Date Posted: 01 - Sep - 2017

BNF chapter: Respiratory system

Expand/Collapse

Treating chronic obstructive pulmonary disease (NICE TA461)

NICE TA461 - Roflumilast for treating chronic obstructive pulmonary disease

Red

Red

Red

Red

Red

Red

Red

Red

Red

Romiplostim

Date Posted: 01 - Nov - 2018

BNF chapter: Blood and Nutrition

Expand/Collapse

Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura (NICE TA221)

NICE TA221 - Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura

Red

Red

Red

Red

Red

Red

Red

Red

Red

Romosozumab

Date Posted: 15 - Jul - 2022

BNF chapter: Endocrine system

Expand/Collapse

Severe osteoporosis (NICE TA791)

NICE TA791 - Romosozumab for treating severe osteoporosis

Green

Green

Green

Green

Green

Green

Green

Green

Green

Ropinirole

Date Posted: 01 - Dec - 2015

BNF chapter: Central nervous system

Expand/Collapse

Restless Legs Syndrome (as per LSCMMG Guidelines)

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Ropinirole

Date Posted: 01 - May - 2013

BNF chapter: Central nervous system

Expand/Collapse

Parkinsons disease

LSCMMG

Green (R)(Restricted)

BwD

Pending

BP

Green

CSR

Green (R)(Restricted)

EL

Pending

FW

Green (R)(Restricted)

GP

Green (R)(Restricted)

MB

Green (R)(Restricted)

WL

Green (R)(Restricted)

Rotigotine

Date Posted: 01 - Dec - 2015

BNF chapter: Central nervous system

Expand/Collapse

Restless Legs Syndrome (as per LSCMMG Guidelines)

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Rotigotine

Date Posted: 01 - Dec - 2015

BNF chapter: Central nervous system

Expand/Collapse

Parkinsons Disease

Red

Red

Red

Red

Red

Red

Red

Red

Red

Roxadustat

Date Posted: 14 - Sep - 2022

BNF chapter: Endocrine system

Expand/Collapse

Treating symptomatic anaemia in chronic kidney disease - NICE TA807

NICE TA807 - Roxadustat for treating symptomatic anaemia in chronic kidney disease

Breadcrumb

Medicine Recommendations

Autoimmune haemolytic anaemia

Idiopathic thrombocytopenia purpura

Membranous glomerulonephritis

Relapsing steroid sensitive nephrotic syndrome in adults

Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and extended prevention of recurrent DVT and PE in adults

Prevention of venous thromboembolism after total hip or total knee replacement in adults (NICE TA170)

Prevention of stroke and systemic embolism in people with atrial fibrillation (NICE TA256)

Treatment of deep vein thrombosis and prevention of recurrent DVT and pulmonary embolism (NICE TA261)

Pulmonary embolism and recurrent venous thromboembolism(NICE TA287)

Preventing adverse outcomes after acute management of acute coronary syndrome (NICE TA335)

Prevention of cardiac events in patients with coronary (CAD) or peripheral artery Disease (PAD) (NICE TA607)

Alzheimer's Dementia (NICE TA 217)

Treating chronic obstructive pulmonary disease (NICE TA461)

Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura (NICE TA221)

Restless Legs Syndrome (as per LSCMMG Guidelines)

Parkinsons disease

Restless Legs Syndrome (as per LSCMMG Guidelines)

Parkinsons Disease

Pulmonary embolism and recurrent venous thromboembolism
(NICE TA287)